Caring Brands (CABR) Income from Continuing Operations (2024 - 2026)
Caring Brands' (CABR) quarterly Income from Continuing Operations came in at 3439427.0 in Q1 2026, down 537.2% year-on-year from 786690.0 in Q1 2025, and up 7.94% quarter-over-quarter from 3736070.0 in Q4 2025.
Caring Brands (CABR) Income from Continuing Operations (2024 - 2026) Analysis & Trends
Caring Brands' Income from Continuing Operations history runs 3 years deep, the most recent figure standing at 3439427.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 537.2% year-over-year to 3439427.0 in Q1 2026; TTM through Mar 2026 was 9361771.0, a N/A change from a year earlier, with the FY2025 full-year figure at 7434669.0, down 2740.12% from the prior year.
- Income from Continuing Operations climbed to 3439427.0 in Q1 2026 per CABR's latest filing, from 3736070.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 428906.0 in Q3 2024 and bottomed at 3736070.0 in Q4 2025.
- The 3-year median for Income from Continuing Operations is 1254647.5 (2024), against an average of 1775578.0.
- Across the five-year window, Income from Continuing Operations slumped 283.88% in 2025 and sank 537.2% in 2026, its largest moves.
- Year by year, Income from Continuing Operations stood at 862791.0 in 2024, then slumped by 333.02% to 3736070.0 in 2025, then increased by 7.94% to 3439427.0 in 2026.
- Per Business Quant, the three latest CABR Income from Continuing Operations figures stand at 3439427.0 (Q1 2026), 3736070.0 (Q4 2025), and 1646504.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Caring Brands | 20.08 Mn | 21.84 Mn | - | -3.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.44 Mn |
| Dec 31, 2025 | -3.74 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | -539,770.00 |
| Dec 31, 2024 | -862,791.00 |
| Sep 30, 2024 | -428,906.00 |